Exploratory/Developmental Grants on Lifestyle Medicine Research Related to the World Trade Center Health Program (R21)
ID: 347747Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$0 - $0

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering Exploratory/Developmental Grants (R21) aimed at advancing Lifestyle Medicine Research related to the World Trade Center (WTC) Health Program. This funding opportunity seeks to support innovative research projects that address chronic diseases associated with the health impacts of the September 11, 2001, attacks, particularly focusing on sustainable health behaviors and lifestyle factors that can improve health outcomes for WTC responders and survivors. With an estimated total program funding of $4 million, the CDC anticipates awarding between 4 to 8 grants, each potentially reaching up to $500,000 over a two-year period. Interested applicants must submit their proposals electronically by 5:00 PM ET on October 29, 2024, and can direct inquiries to James Yiin, PhD, at JYiin@cdc.gov for further information.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institute for Occupational Safety and Health (NIOSH), announces funding for Exploratory/Developmental Grants (R21) focused on Lifestyle Medicine Research pertaining to the World Trade Center (WTC) Health Program, specifically addressing the health impacts of the September 11, 2001, attacks. This initiative aims to support research projects that enhance understanding and treatment of chronic diseases identified as WTC-related conditions. Key research areas include screening methods to identify at-risk populations, lifestyle interventions for managing diseases, and program evaluations to improve WTC health initiatives. Applicants are encouraged to propose innovative studies with minimal preliminary data, fostering the exploration of new methodologies or interventions. Total funding available is approximately $4 million, with individual awards up to $500,000 over two years expected for 4 to 8 projects. Eligible applicants include higher education institutions, nonprofits, government entities, and small businesses. The application process involves strict adherence to guidelines, ensuring submissions are scientifically distinct, ethically sound, and inclusive of underrepresented populations. This funding opportunity reflects a commitment to advancing public health research for those affected by the September 11 attacks and its associated health challenges.
    The World Trade Center (WTC) Health Program's Notice of Funding Opportunity (NOFO) RFA-OH-24-002 addresses application requirements for funding aimed at health initiatives following the events of 9/11. It is a reissue of the previous RFA-OH-23-001, which has expired, and applicants are instructed to follow updated guidance for resubmissions, including the need for a 1-page Introduction to Application addressing reviewer feedback. The document clarifies the distinction between two R21 NOFOs issued for FY24: RFA-OH-24-003 focuses solely on survivors, including WTC Youth, whereas RFA-OH-24-002 includes both responders and survivors with a concentration on Lifestyle Medicine research. Each NOFO has specific financial parameters, with a maximum budget of $365K annually for two years and differing performance periods based on application type. This funding initiative demonstrates the federal government's commitment to providing health support for individuals affected by the WTC disaster through targeted research and community health programs. Overall, RFA-OH-24-002 is indicative of a structured approach to federal grants reflecting evolving needs and feedback from past funding cycles.
    Similar Opportunities
    Exploratory/Developmental Research for World Trade Center Health Program Evidence-based Strategies to Improve Treatment Effectiveness, Diagnostic Practices, and Program Evaluation (R21)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a Notice of Funding Opportunity (NOFO) for exploratory and developmental research (R21) aimed at improving treatment effectiveness and diagnostic practices for health conditions related to the September 11, 2001, terrorist attacks under the World Trade Center (WTC) Health Program. This initiative seeks innovative research addressing uncertainties in diagnosing and treating conditions among WTC responders and survivors, with a focus on health equity for vulnerable populations. The program anticipates awarding between 4 to 8 grants, with an estimated total funding of $4 million available over two years, and applications are due by October 29, 2024. Interested applicants can reach out to James Yiin, PhD, at JYiin@cdc.gov for further information.
    Exploratory/Developmental Grants Related to the World Trade Center Survivors (R21-No Applications with Responders Accepted)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering exploratory and developmental grants (R21) focused on research related to World Trade Center (WTC) survivors, specifically addressing diagnostic and treatment uncertainties stemming from the September 11, 2001, terrorist attacks. The initiative aims to support projects that investigate physical and mental health conditions affecting WTC survivors, with a particular emphasis on improving healthcare for at-risk populations, including minorities and pregnant women. This funding opportunity, with an estimated total program funding of $4 million and an expected eight awards, has a performance period of two years and requires applications to be submitted electronically by 5:00 PM ET on October 29, 2024. For further details, interested applicants can contact James Yiin, PhD, at JYiin@cdc.gov or visit the additional information link provided in the opportunity overview.
    Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity for Cooperative Research Agreements related to the World Trade Center (WTC) Health Program, aimed at addressing health conditions stemming from the September 11, 2001, terrorist attacks. This initiative seeks scientifically rigorous research proposals that focus on improving diagnosis and treatment, expanding knowledge about health effects, and enhancing response strategies for future disasters, particularly for WTC responders and survivors. With an estimated total program funding of $41.25 million and an award ceiling of $550,000, the CDC anticipates making approximately 25 awards. Interested applicants can reach out to Dr. James Yiin at JYiin@cdc.gov or call 513-841-4271 for further information, with applications due by October 28, 2025, and awards expected to be announced by June 26, 2026.
    World Trade Center Health Program Mentored Research Scientist Career Development Award (K01)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering the World Trade Center Health Program Mentored Research Scientist Career Development Award (K01) to support junior research scientists in advancing their careers in WTC-related health research. This grant provides funding for up to three years, allowing for 75% protected time dedicated to mentored research experiences, aimed at addressing diagnostic and treatment uncertainties faced by individuals affected by the 9/11 attacks. The program emphasizes research in key areas such as health services, health equity, treatment, prevention, and quality of life, with an estimated total funding of $5.2 million available for 6 to 10 awards. Interested applicants must submit their proposals by October 29, 2024, and can reach out to James Yiin, PhD, at JYiin@cdc.gov for further information.
    Assessment and Evaluation of Emerging Health Conditions Relevant to the World Trade Center Health Program (U01)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity titled "Assessment and Evaluation of Emerging Health Conditions Relevant to the World Trade Center Health Program (U01)." This cooperative agreement aims to support research projects that investigate health conditions potentially related to the September 11, 2001, terrorist attacks, focusing on diagnosing and treating conditions that have emerged since the establishment of the WTC Health Program. The initiative is particularly interested in interdisciplinary collaborations that address health equity and the health burdens faced by vulnerable populations exposed to the 9/11 attacks. The estimated total program funding is $33 million, with an award ceiling of $550,000 and approximately 20 awards expected. Interested applicants can reach out to Dr. James Yiin at JYiin@cdc.gov or by phone at 513-841-4271, with applications due by October 28, 2025, and awards anticipated by June 26, 2026.
    NIOSH Exploratory/Developmental Grant Program (R21)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering the NIOSH Exploratory/Developmental Grant Program (R21) to support innovative research aimed at understanding and mitigating risks associated with occupational diseases and injuries. This grant program seeks to fund projects that explore methods for reducing workplace hazards and translating scientific findings into effective prevention strategies, thereby addressing the significant burden of occupational health issues. Eligible applicants include a diverse range of entities such as higher education institutions, nonprofits, and various government organizations, with a total funding pool of $1 million available, allowing for awards up to $200,000 per project over a two-year period. Interested parties must submit their applications by November 17, 2024, and can find additional information and application guidelines at the provided link or by contacting the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV.
    Occupational Safety and Health Education and Research Centers (T42)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is inviting grant applications for the Occupational Safety and Health Education and Research Centers (T42) program, aimed at enhancing occupational safety and health training. This initiative seeks to establish Education and Research Centers (ERCs) at academic institutions that will provide interdisciplinary graduate and post-graduate training, research, and outreach in core occupational safety and health disciplines, thereby ensuring a qualified workforce to meet the mandates of the Occupational Safety and Health Act. With an estimated total program funding of $32 million and an award ceiling of $9 million, the CDC anticipates making approximately 18 awards, with applications due by November 21, 2024. Interested applicants can reach out to Dr. Elizabeth H. Maples at emaples@cdc.gov or by phone at 404-498-2557 for further information.
    Research Grants for Preventing Violence and Violence Related Injury (R01)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering research grants aimed at preventing violence and violence-related injuries through the R01 funding mechanism. This initiative seeks investigator-initiated research that evaluates innovative programs, practices, or policies designed to address the risk of violence, particularly among communities disproportionately affected by such issues. The funding is crucial for advancing understanding of effective strategies to mitigate community violence, especially among youth and young adults aged 10-34 years. With an estimated total program funding of $9.6 million and a maximum award ceiling of $400,000, applications must be submitted electronically by December 2, 2024, to be considered. For further inquiries, interested applicants can contact Mikel Walters at ncipcerpo@cdc.gov.
    K01 Mentored Research Scientist Development Award
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering the K01 Mentored Research Scientist Development Award, a federal grant aimed at supporting the career development of junior researchers in occupational safety and health. This grant provides funding for a three-year period, allowing for 75% protected time dedicated to research and training, with the goal of achieving research independence while addressing significant occupational health burdens. Eligible applicants include a diverse range of institutions such as higher education institutions, nonprofits, and state governments, with a focus on research topics aligned with NIOSH's strategic goals, including musculoskeletal disorders and respiratory diseases. The estimated total program funding is $500,000, with an award ceiling of $100,000, and applications are due by November 17, 2024. For more information, interested parties can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the additional information link provided.
    RFA-DD-18-000
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-DD-18-000, aimed at supporting health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with the program expected to award approximately 10 grants. This funding is crucial for enhancing public health efforts, although specific funding amounts have not been disclosed. Interested parties should submit their applications by October 13, 2025, and can direct inquiries to Linton C. Browning at lbrowning@cdc.gov or by phone at 770-488-2756.